跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALOCANE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ALOCANE
Authorized
STANDARD
ALOCANE
quest products, llc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c56f74e917b102d3
Company
quest products, llc
Type
Standard
Approval Details
Approval Id
c56f74e917b102d3
Drug Approval Canada Name
ALOCANE
Product Name
ALOCANE
Status
Marketed
Status Date
2022-01-27
Original Market Date
2022-01-27
Din
02519917
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:08.00
Atc Original
D04AB01 LIDOCAINE
Atc Name
d 04 ab 01
Aig Number
0101280002
Company Name
quest products, llc
Company Address
200, 8201 104 St, Pleasant Prairie, Wisconsin, United States, 53158
Active Ingredients
LIDOCAINE HYDROCHLORIDE
4 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c56f74e917b102d3
Type
Standard
Back to Health Canada Approvals